Sources

12 Total Sources

Johnson & Johnson Buys Firefly Bio for $1 Billion to Enter KRAS Cancer Drug Race

Left60%

Center40%

Johnson & Johnson Acquires Firefly Bio for $1 Billion to Enter KRAS Cancer Treatment Market

StockTitan7h ago

Johnson & Johnson to acquire Firefly Bio in $1B deal | JNJ Stock News

Fierce Biotech7h ago

Deals | Fierce Biotech

Johnson & Johnson19h ago

Johnson & Johnson Innovative Medicine

IndexBox, Inc.4h ago

J&J Acquires Firefly Bio: $1B Deal Targets KRAS-Driven Cancers with Protein-Degrading Technology - News and Statistics - IndexBox

Yahoo Finance7h ago

J&J to buy cancer drug technology developer Firefly Bio for $1 billion

intellectia.ai7h ago

Johnson & Johnson Acquires Firefly Bio for $1B to Enhance Oncology Pipeline | Intellectia.AI

Johnson & Johnson7h ago

Johnson & Johnson to Acquire Firefly Bio for $1 Billion, Expanding Oncology Pipeline with DAC Platform

Las Vegas Sun7h ago

Johnson & Johnson to Acquire Firefly Bio, Inc. to Expand Oncology Pipeline with Novel Degrader Antibody Conjugate Platform - Las Vegas Sun News

J&J to buy cancer drug technology developer Firefly Bio for $1 billion

M&A News: Johnson & Johnson (JNJ) Reaches a Massive $1B Deal for Firefly Bio to Expand Its Oncology Pipeline - TipRanks.com

FirstWord Pharma7h ago

J&J inks $1B deal for Firefly Bio and its degrader-antibody platform | FirstWord Pharma